Ultragenyx Pharmaceutical
RARE
#3251
Rank
โ‚ฌ3.23 B
Marketcap
33,50ย โ‚ฌ
Share price
-4.26%
Change (1 day)
-23.03%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2023 (TTM): -9,78ย โ‚ฌ

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -9,47ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -9,35ย โ‚ฌ a decrease over its 2021 EPS that were of -6,21ย โ‚ฌ.

EPS history for Ultragenyx Pharmaceutical from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-9,78ย โ‚ฌ4.58%
2022-9,35ย โ‚ฌ50.67%
2021-6,21ย โ‚ฌ113.69%
2020-2,90ย โ‚ฌ-55.9%
2019-6,59ย โ‚ฌ82.56%
2018-3,61ย โ‚ฌ-45.15%
2017-6,58ย โ‚ฌ14.68%
2016-5,74ย โ‚ฌ57.36%
2015-3,64ย โ‚ฌ69.83%
2014-2,15ย โ‚ฌ15.22%
2013-1,86ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
0,72ย โ‚ฌ-107.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,59ย โ‚ฌ-93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,61ย โ‚ฌ-72.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,63ย โ‚ฌ-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA